Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oncovox - An Acceptance and Commitment Therapy Guided Online Intervention to Improve Quality of Life in Breast Cancer Patients: a Randomised Clinical Trial

NCT05161312 is registered in ClinicalTrials.gov with Babes-Bolyai University as lead sponsor.

NCT NCT05161312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05161312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oncovox - An Acceptance and Commitment Therapy Guided Online Intervention to Improve Quality of Life in Breast Cancer Patients: a Randomised Clinical Trial
Lead sponsor
Babes-Bolyai University
Phase
Not applicable
Overall status
Completed
Start date
November 15, 2021
Completion date
May 25, 2022
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, breast, distress, emotional, quality of life